Wolverine Trading, LLC Biotechnology

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
APLT
Applied Therapeutics Inc.
CALL
$211,000
24.9K
Q2 2024
New holding
ROIV
Roivant Sciences Ltd.
CALL
$208,000
18.1K N/A
ARWR
Arrowhead Pharmaceuticals, Inc.
PUT
$203,000
10.5K
Q1 2024
Reduced 70.09%
LQDA
Liquidia Corp
PUT
$189,000
18.9K
Q2 2024
Reduced 42.5%
FULC
Fulcrum Therapeutics, Inc.
CALL
$185,000
52.1K
Q1 2024
Added 71.52%
AVXL
Anavex Life Sciences Corp.
CALL
$179,000
31.6K
Q3 2024
New holding
EYPT
Eye Point Pharmaceuticals, Inc.
PUT
$174,000
21.9K
Q3 2021
Closed
OMER
Omeros Corp
CALL
$158,000
40K
Q3 2024
Added 19.82%
HUMA
Humacyte, Inc.
CALL
$151,000
27.9K
Q3 2024
Added 35.59%
BMEA
Biomea Fusion, Inc.
PUT
$147,000
14.6K
Q3 2024
New holding
CRVS
Corvus Pharmaceuticals, Inc.
CALL
$145,000
27.5K
Q3 2022
New holding
ROIV
Roivant Sciences Ltd.
PUT
$144,000
12.5K N/A
HUMA
Humacyte, Inc.
PUT
$143,000
26.4K
Q3 2024
Added 35.59%
ALDX
Aldeyra Therapeutics, Inc.
CALL
$140,000
26.1K
Q3 2023
Added 16.75%
SAGE
Sage Therapeutics, Inc.
CALL
$137,000
19.1K
Q4 2021
Reduced 29.62%
EYPT
Eye Point Pharmaceuticals, Inc.
CALL
$119,000
15K
Q3 2021
Closed
CRMD
Cor Medix Inc.
PUT
$118,000
14.7K
Q3 2024
Reduced 16.02%
CDMO
Avid Bioservices, Inc.
PUT
$114,000
10.1K
Q3 2019
New holding
CCCC
C4 Therapeutics, Inc.
CALL
$105,000
18.5K N/A
OMER
Omeros Corp
PUT
$102,000
25.7K
Q3 2024
Added 19.82%
QURE
Uni Qure N.V.
CALL
$91,000
18.5K
Q3 2024
Reduced 54.6%
EDIT
Editas Medicine, Inc.
CALL
$84,000
24.9K
Q3 2024
New holding
ABUS
Arbutus Biopharma Corp
PUT
$80,000
20.8K
Q3 2022
Reduced 5.77%
CRDF
Cardiff Oncology, Inc.
PUT
$75,000
28.1K
Q3 2024
Added 95.73%
CRVS
Corvus Pharmaceuticals, Inc.
PUT
$74,000
14.1K
Q3 2022
New holding
GERN
Geron Corp
PUT
$72,000
15.9K
Q3 2024
New holding
VNDA
Vanda Pharmaceuticals Inc.
CALL
$70,000
15K
Q3 2024
New holding
RLMD
Relmada Therapeutics, Inc.
CALL
$68,000
21.1K
Q1 2024
Added 7.74%
AKBA
Akebia Therapeutics, Inc.
CALL
$63,000
48.1K
Q2 2023
New holding
AVXL
Anavex Life Sciences Corp.
PUT
$62,000
11K
Q3 2024
New holding
OCGN
Ocugen, Inc.
CALL
$61,000
61.9K
Q1 2024
New holding
FULC
Fulcrum Therapeutics, Inc.
PUT
$60,000
17K
Q1 2024
Added 71.52%
ATOS
Atossa Therapeutics, Inc.
CALL
$57,000
37.5K
Q3 2024
Added 32.35%
AMLX
Amylyx Pharmaceuticals, Inc.
CALL
$54,000
16.9K
Q1 2024
New holding
NKTX
Nkarta, Inc.
CALL
$45,000
10.1K
Q4 2022
New holding
CDXC
Chroma Dex Corp.
CALL
$44,000
12.3K
Q2 2024
Reduced 34.63%
RVNC
Revance Therapeutics, Inc.
CALL
$41,000
16.2K
Q1 2024
New holding
EDIT
Editas Medicine, Inc.
PUT
$41,000
12.3K
Q3 2024
New holding
CRDF
Cardiff Oncology, Inc.
CALL
$41,000
15.6K
Q3 2024
Added 95.73%
MCRB
Seres Therapeutics, Inc.
CALL
$34,000
36.5K
Q3 2024
Reduced 11.79%
VERU
Veru Inc.
CALL
$31,000
41.2K
Q4 2022
Reduced 52.24%
MCRB
Seres Therapeutics, Inc.
PUT
$30,000
32K
Q3 2024
Reduced 11.79%
QSI
Quantum Si Inc
CALL
$23,000
27.2K
Q3 2024
Reduced 7.77%
GOSS
Gossamer Bio, Inc.
CALL
$22,000
23.1K
Q3 2024
Reduced 43.69%
RGLS
Regulus Therapeutics Inc.
CALL
$21,000
13.7K N/A
OCGN
Ocugen, Inc.
PUT
$21,000
22K
Q1 2024
New holding
AMRN
Amarin Corp Plcuk
CALL
$19,000
30.4K
Q4 2022
Reduced 43.9%
IMUX
Immunic, Inc.
PUT
$19,000
11.7K
Q3 2024
New holding
LXRX
Lexicon Pharmaceuticals, Inc.
CALL
$18,000
11.9K
Q3 2024
New holding
Filter Shares Options
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email